All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional.
Introducing
Now you can personalise
your GvHD Hub experience!
Bookmark content to read later
Select your specific areas of interest
View content recommended for you
Find out moreThe GvHD Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the GvHD Hub cannot guarantee the accuracy of translated content. The GvHD Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
Bookmark this article
A study by Lucie Turcotte, University of Minnesota Blood and Marrow Transplant Program, Minneapolis, and colleagues, evaluated if there were associations between donor body mass index (BMI) and graft-versus-host-disease (GvHD). The authors noted that more than one-third of hematopoietic cell transplantation (HCT) donors are obese but there have not yet been any studies to examine the outcomes. The results of the analysis were published in Bone Marrow Transplantation in July 2018.
The authors concluded that from their study there were no consistent and significant trends to suggest that donor BMI was associated with aGvHD, cGvHD, relapse, DFS, NRM or OS. Although there was a limited number of morbidly obese donors, donor obesity was not considered a risk for GvHD or other adverse outcomes of HCT.
Subscribe to get the best content related to GvHD delivered to your inbox